Search Results 801-810 of 18155 for monoclonal antibody

  1. Axicabtagene Ciloleucel Expanded Access Study - Mayo Clinic

    anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative, and; an anthracycline containing chemotherapy regimen;. No evidence ...

  2. Hematology - Clinical trials

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  3. Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer - Mayo Clinic

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  4. Study Of Pembrolizumab (MK-3475) In Participants With Relapsed Or Refractory Primary Mediastinal Large B-cell Lymphoma Or Relapsed Or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

    Prior monoclonal antibody within 4 weeks prior to study Day 1 (2 weeks for RS participants) or who has not recovered (i.e. ≤ Grade 1 or at baseline) from ...

  5. DeeDee Stiepan | Mayo Clinic News Network - Page 17 of 25

    Monoclonal antibody treatment can help high-risk patients with COVID-19. By DeeDee Stiepan • December 4, 2020. Mayo Clinic leader discusses post-Thanksgiving ...

  6. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab and pembrolizumab, may help the body's immune system attack the cancer, and may ...

  7. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

  8. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  9. Tucatinib And Trastuzumab For Patients With HER2-positive Metastatic Colorectal Cancer - Mayo Clinic

    ... monoclonal antibody (bevacizumab, ramucirumab, or ziv-aflibercept), and an anti-PD-1 monoclonal antibody (nivolumab or pembrolizumab) if tumor has deficient ...

  10. A Controlled Clinical Study Of Dupilumab In Patients With Nasal Polyps

    Any experimental monoclonal antibody (mAB) within 5 half-lives or within 6 months before V1 if the half-life is unknown. Anti-immunoglobulin E (IgE) therapy ...